OmniAb/$OABI
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About OmniAb
OmniAb Inc licenses discovery research technology to pharmaceutical and biotech companies and academic institutions to enable the discovery of next-generation therapeutics. Its technology platform creates and screens diverse antibody repertoires and is designed to quickly identify optimal antibodies and other target-binding proteins for its partners' drug development efforts. At the heart of the OmniAb platform is what it calls Biological Intelligence, which powers the immune systems of proprietary, engineered transgenic animals to create optimized antibody candidates for human therapeutics.
Ticker
$OABI
Sector
Primary listing
Employees
89
Headquarters
Website
OmniAb Metrics
BasicAdvanced
$265M
-
-$0.57
0.85
-
Price and volume
Market cap
$265M
Beta
0.85
52-week high
$3.34
52-week low
$1.22
Average daily volume
315K
Financial strength
Current ratio
4.02
Quick ratio
3.778
Long term debt to equity
6.162
Total debt to equity
7.615
Profitability
EBITDA (TTM)
-46.89
Gross margin (TTM)
98.38%
Net profit margin (TTM)
-347.04%
Operating margin (TTM)
-350.07%
Effective tax rate (TTM)
2.29%
Revenue per employee (TTM)
$210,000
Management effectiveness
Return on assets (TTM)
-13.04%
Return on equity (TTM)
-23.36%
Valuation
Price to revenue (TTM)
11.141
Price to book
0.99
Price to tangible book (TTM)
4.56
Price to free cash flow (TTM)
-5.617
Free cash flow yield (TTM)
-17.80%
Free cash flow per share (TTM)
-0.326
Growth
Revenue change (TTM)
-29.27%
Earnings per share change (TTM)
-5.93%
3-year revenue growth (CAGR)
-31.89%
3-year earnings per share growth (CAGR)
29.62%
OmniAb News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for OmniAb stock?
OmniAb (OABI) has a market cap of $265M as of March 17, 2026.
What is the P/E ratio for OmniAb stock?
The price to earnings (P/E) ratio for OmniAb (OABI) stock is 0 as of March 17, 2026.
Does OmniAb stock pay dividends?
No, OmniAb (OABI) stock does not pay dividends to its shareholders as of March 17, 2026.
When is the next OmniAb dividend payment date?
OmniAb (OABI) stock does not pay dividends to its shareholders.
What is the beta indicator for OmniAb?
OmniAb (OABI) has a beta rating of 0.85. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.